Affymetrix Inc.
3420 Central Expressway
Santa Clara,
CA 95051
United States - Map
Phone: 408-731-5000
Fax: 408-731-5380
Web Site: http://www.affymetrix.com
| Affymetrix, Inc. engages in the development, manufacture, sale, and servicing of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The company offers integrated GeneChip microarray platform that includes disposable DNA probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. Its products are used in various applications, including the monitoring of gene or exon expression levels and investigation of genetic variation. The company sells its products directly to pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies; academic research centers; government research laboratories; private foundation laboratories; and clinical reference laboratories in North America and Europe, as well as through life science supply specialists acting as authorized distributors in Latin America, India, the Middle East, and the Asia Pacific regions, including the Peoples Republic of China. It has collaboration partnerships with Caliper Life Sciences, CapitalBio Corporation, Life Technologies, Pathwork Diagnostics, PreAnalutiX GmbH, and Qiagen GmbH. The company was founded in 1991 and is headquartered in Santa Clara, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Stephen P.A. Fodor Ph.D., 55
Founder and Exec. Chairman |
$
655.00K |
$
0 | Mr. Kevin M. King , 52
Chief Exec. Officer, Pres |
$
491.00K |
$
0 | Mr. John C. Batty , 54
Chief Financial Officer, Principal Accounting Officer and Exec. VP |
$
376.00K |
$
0 | Mr. John F. Runkel Jr., 53
Exec. VP, Sec. and Gen. Counsel |
$
62.00K |
$
0 | Dr. Richard Rava Ph.D,
Scientific Co-Founder and Head of Product Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
0.07 (1.45%) 
Profile
